Literature DB >> 31162888

Clinical predictors of cystic fibrosis chronic rhinosinusitis severity.

Anna C Zemke1, Seyed Mehdi Nouraie1, John Moore2, Jordan R Gaston3, Nicholas R Rowan2, Joseph M Pilewski1, Jennifer M Bomberger3, Stella E Lee2.   

Abstract

BACKGROUND: Chronic rhinosinusitis (CRS) is a significant manifestation of cystic fibrosis (CF) with wide-ranging symptom and disease severity. The goal of the study was to determine clinical variables that correlate with outcome measures of disease severity.
METHODS: A prospective, longitudinal, observational study of 33 adults with symptomatic CRS treated in a CF-focused otolaryngology clinic was performed. Symptom severity, the presence of rhinosinusitis exacerbations, and endoscopic appearance were assessed, and regression analysis was used to determine clinical predictors of disease outcome.
RESULTS: Thirty-three adults with CF-CRS were included in the study and followed for a mean of 15 months. Rhinosinusitis exacerbations occurred in 61% of participants during the study, and female sex increased the odds of presenting with an exacerbation visit. Sinus disease exacerbations were associated with an odds ratio of 2.07 for presenting with a pulmonary exacerbation at the next visit. CF-related diabetes was found to be associated with worse symptoms and endoscopic appearance. Infection with Staphylococcus aureus predicted worsening of symptoms, whereas infections with Pseudomonas aeruginosa improved over time. Allergic rhinitis was associated with worse endoscopic appearance, and nasal steroid use was associated with improved endoscopic appearance.
CONCLUSION: Sex, CF-related diabetes, sinonasal infection status, allergic rhinitis, and nasal steroid use may all modulate severity of CF-CRS in adults. Sinusitis exacerbation may be a precursor to pulmonary exacerbation.
© 2019 ARS-AAOA, LLC.

Entities:  

Keywords:  Pseudomonas aeruginosa; chronic rhinosinusitis; cystic fibrosis; diabetes mellitus; exacerbation; sinusitis

Mesh:

Substances:

Year:  2019        PMID: 31162888      PMCID: PMC6715283          DOI: 10.1002/alr.22332

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  32 in total

1.  A comparison of microbiologic flora of the sinuses and airway among cystic fibrosis patients with maxillary antrostomies.

Authors:  A Dosanjh; S Lakhani; D Elashoff; C Chin; V Hsu; B Hilman
Journal:  Pediatr Transplant       Date:  2000-08

2.  Nasal polyposis in patients with cystic fibrosis.

Authors:  H SHWACHMAN; L L KULCZYCKI; H L MUELLER; C G FLAKE
Journal:  Pediatrics       Date:  1962-09       Impact factor: 7.124

3.  Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response.

Authors:  Helle Krogh Johansen; Kasper Aanaes; Tania Pressler; Kim Gjerrum Nielsen; Jacob Fisker; Marianne Skov; Niels Høiby; Christian von Buchwald
Journal:  J Cyst Fibros       Date:  2012-05-15       Impact factor: 5.482

4.  CT of the paranasal sinuses is not a valid indicator for sinus surgery in CF patients.

Authors:  Jacob Rasmussen; Kasper Aanæs; Rikke Norling; Kim G Nielsen; Helle Krogh Johansen; Christian von Buchwald
Journal:  J Cyst Fibros       Date:  2011-10-20       Impact factor: 5.482

5.  Microbiology of the Upper and Lower Airways in Pediatric Cystic Fibrosis Patients.

Authors:  Lindsay Sobin; Kosuke Kawai; Alexandria L Irace; Ozgul Gergin; Michael Cunningham; Gregory S Sawicki; Eelam A Adil
Journal:  Otolaryngol Head Neck Surg       Date:  2017-04-25       Impact factor: 3.497

6.  Importance to question sinonasal symptoms and to perform rhinoscopy and rhinomanometry in cystic fibrosis patients.

Authors:  J M Bock; M Schien; C Fischer; L Naehrlich; M Kaeding; O Guntinas-Lichius; A Gerber; C Arnold; J G Mainz
Journal:  Pediatr Pulmonol       Date:  2016-11-28

7.  Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes.

Authors:  D H Limoli; J Yang; M K Khansaheb; B Helfman; L Peng; A A Stecenko; J B Goldberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-03-18       Impact factor: 3.267

8.  Risk factors for rate of decline in FEV1 in adults with cystic fibrosis.

Authors:  Michael W Konstan; Jeffrey S Wagener; Donald R Vandevanter; David J Pasta; Ashley Yegin; Lawrence Rasouliyan; Wayne J Morgan
Journal:  J Cyst Fibros       Date:  2012-05-05       Impact factor: 5.482

9.  Comparison of radiographic and clinical characteristics of low-risk and high-risk cystic fibrosis genotypes.

Authors:  Geoffrey R Ferril; Jerry A Nick; Anne E Getz; Henry P Barham; Milene T Saavedra; Jennifer L Taylor-Cousar; David P Nichols; Douglas Curran-Everett; Todd T Kingdom; Vijay R Ramakrishnan
Journal:  Int Forum Allergy Rhinol       Date:  2014-09-15       Impact factor: 3.858

10.  Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society.

Authors:  Antoinette Moran; Carol Brunzell; Richard C Cohen; Marcia Katz; Bruce C Marshall; Gary Onady; Karen A Robinson; Kathryn A Sabadosa; Arlene Stecenko; Bonnie Slovis
Journal:  Diabetes Care       Date:  2010-12       Impact factor: 19.112

View more
  8 in total

1.  Interplay between host-microbe and microbe-microbe interactions in cystic fibrosis.

Authors:  Catherine R Armbruster; Tom Coenye; Lhousseine Touqui; Jennifer M Bomberger
Journal:  J Cyst Fibros       Date:  2019-11-02       Impact factor: 5.482

2.  Adaptation and genomic erosion in fragmented Pseudomonas aeruginosa populations in the sinuses of people with cystic fibrosis.

Authors:  Catherine R Armbruster; Christopher W Marshall; Arkadiy I Garber; Jeffrey A Melvin; Anna C Zemke; John Moore; Paula F Zamora; Kelvin Li; Ian L Fritz; Christopher D Manko; Madison L Weaver; Jordan R Gaston; Alison Morris; Barbara Methé; William H DePas; Stella E Lee; Vaughn S Cooper; Jennifer M Bomberger
Journal:  Cell Rep       Date:  2021-10-19       Impact factor: 9.423

Review 3.  Chronic rhinosinusitis in patients with cystic fibrosis-Current management and new treatments.

Authors:  Brian Jake Johnson; Garret W Choby; Erin K O'Brien
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-06-13

4.  Longitudinal analysis of sinus microbiota post endoscopic surgery in patients with cystic fibrosis and chronic rhinosinusitis: a pilot study.

Authors:  Brett Wagner Mackenzie; Camila Dassi; Anitha Vivekanandan; Melissa Zoing; Richard G Douglas; Kristi Biswas
Journal:  Respir Res       Date:  2021-04-13

5.  Impact of Cystic Fibrosis Transmembrane Conductance Regulator Therapy on Chronic Rhinosinusitis and Health Status: Deep Learning CT Analysis and Patient-reported Outcomes.

Authors:  Daniel M Beswick; Stephen M Humphries; Connor D Balkissoon; Matthew Strand; Eszter K Vladar; David A Lynch; Jennifer L Taylor-Cousar
Journal:  Ann Am Thorac Soc       Date:  2022-01

6.  Olfactory dysfunction in people with cystic fibrosis with at least one copy of F508del.

Authors:  Daniel M Beswick; Stephen M Humphries; Connor D Balkissoon; Matthew Strand; Jessa E Miller; Aastha Khatiwada; Eszter K Vladar; David A Lynch; Jennifer L Taylor-Cousar
Journal:  Int Forum Allergy Rhinol       Date:  2022-01-14       Impact factor: 5.426

7.  Cystic Fibrosis Foundation otolaryngology care multidisciplinary consensus recommendations.

Authors:  Adam J Kimple; Brent A Senior; Edward T Naureckas; David A Gudis; Ted Meyer; Sarah E Hempstead; Helaine E Resnick; Dana Albon; Wayne Barfield; Margo McKenna Benoit; Daniel M Beswick; Eliza Callard; Shelagh Cofer; Veronica Downer; E Claire Elson; Angela Garinis; Ashleigh Halderman; Lisa Hamburger; Meagan Helmick; Michael McCown; Cameron J McKinzie; Hanna Phan; Kenneth Rodriguez; Ronald C Rubenstein; Ashley Severin; Gopi Shah; Ambika Shenoy; Brittney Sprouse; Frank Virgin; Bradford A Woodworth; Stella E Lee
Journal:  Int Forum Allergy Rhinol       Date:  2022-02-22       Impact factor: 5.426

Review 8.  Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases Workshop.

Authors:  Robert Naclerio; Fuad Baroody; Claus Bachert; Benjamin Bleier; Larry Borish; Erica Brittain; Geoffrey Chupp; Anat Fisher; Wytske Fokkens; Philippe Gevaert; David Kennedy; Jean Kim; Tanya M Laidlaw; Jake J Lee; Jay F Piccirillo; Jayant M Pinto; Lauren T Roland; Robert P Schleimer; Rodney J Schlosser; Julie M Schwaninger; Timothy L Smith; Bruce K Tan; Ming Tan; Elina Toskala; Sally Wenzel; Alkis Togias
Journal:  J Allergy Clin Immunol Pract       Date:  2020-03-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.